Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Verrica Pharmaceuticals Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 59 | 34 | −25 |
| SharesConverted for a 1-for-10 split | 2.49M | 2.47M | −19.4K (−0.8%) |
| Value | $13.4M | $10.6M | −$2.86M (−21.3%) |
New holders (6)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Boothbay Fund Management, LLC | 280,734 | $1.21M | 0.03% |
| Bridgeway Capital Management, LLC | 12,000 | $51.7K | 0.00% |
| New England Capital Financial Advisors LLC | 200 | $862 | 0.00% |
| Optiver Holding B.V. | 31 | $134 | 0.00% |
| SRS Capital Advisors, Inc. | 9 | $38 | 0.00% |
| MAI Capital Management | 2 | $9 | 0.00% |
Sold out (31)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q2 2025 and filed for Q3 2025 without it.